Solactive China Biotech Index - CNY - Benchmark TR Net
Replication method
Physical
Management style
Passive
Distributes
Capital Gains
Primary advisor
Mirae Asset Global Investments (Hong Kong) Ltd.
ISIN
HK0000516697
The Global X China Biotech ETF seeks to provide investment results that, before deduction of fees and expenses, closely correspond to the performance of the Underlying Index.